← SynDRA
Melanostatin
SynDRA canonical compound SYN1990797 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | melanocyte-stimulating hormone release inhibitor |
|---|
Drug classes
Cross-references
Synonyms
- MIF-I
- MIF-1
- H-Pro-Leu-Gly-NH2
- Pro-Leu-Gly-NH2
- prolylleucylglycinamide
- Pro-Leu-Glyamide
- Prol-Leu-Gly-NH2
- Oxytocin (7-9)
- Prolyl-Leucyl-Glycinamide
- RefChem:925443
- 4J2YQP4NA3
- MSH release-inhibiting factor
- L-Prolyl-L-leucylglycinamide
- Oxytocin C-terminal tripeptide
- 7-9-Oxytocin
- Melanostatin I (ox)
- MSH RELEASE-INHIBITING FACTOR I
- Prolylleucylglycine amide
- L-Prolyl-L-leucylglycylamide
- Glycinamide, L-prolyl-L-leucyl-
- L-Proline-L-leucine-glycine-amide
- 3KY24B4Q62
- MFCD00037866
- Pro-Leu-Gly amide
- UNII-3KY24B4Q62
- Prolyl-L-leucyl-glycinamide, L-
- EINECS 217-902-7
- L-pro-L-leu-gly-NH2
- MELANOSTATIN MIF-I
- orb525682
- SCHEMBL362530
- MELANOSTATIN MIF-I [MI]
- CHEBI:168693
- NOOJLZTTWSNHOX-UWVGGRQHSA-N
- GLXC-23941
- MIF-I, (-)-
- BDBM50060601
- EX-A15816
- HB1874
Look up Melanostatin in the interactive SynDRA portal →